I’m still loving the absolutely obvious step downs the MMs are using to pick up retail shares at incremental levels.

Blarcamesine’s Phase III clinical trials show similar levels of significant improvement in communication and interaction, as patients had statistically significant improvement in the RSBQ primary endpoint of 72.2% compared to 38.5% on placebo. .

I think big money has been adding at support levels as this has risen from $8 to $11

$AVXL At this level, the remaining float could easily get locked up by institutional investors and they will likely come in the next days/weeks for this very high reward / low risk company.

So the current price level is so cheap and has so little downside that even with concerns about data and approval, the stock can rise 5x from here.

Multiple levels of support below current share price.

Nice little stop loss hunt and test of a Fibonacci level.

$AVXL Hot Level 2 buying

way above these levels.

I will just add a bit more today at these levels and enjoy the ride.

Could be an almost vertical move to the $34 level best cast.

Over 4x return from those levels, and much more to come.

$TGTX tutes are now aggressively accumulating at this level because they all know that this only has one way to go and that is up 🆙↗️↗️↗️⬆️💰💰💰 Follow the 💴

VRAX is starting a big breakout from all-time-low levels.

ALLR is starting a big breakout from all-time-low levels.

Folks, we have a great level of CEO risk here.

Even after it fell back it is still way above the level where I told people to short it

Excellent consolidation occuring at this level.

This could be a great trade if the level continues to hold.

$SRZN held up nicely throughout the chaos in the Market today, expecting some big things from this one very soon after it's finished consolidating in this level.

Anything above this level just warms my heart.

$SAVA In at $20, haven’t checked this in a while, glad to see it at these levels, holding long +++

Thanks for getting this stock price back to an affordable level and for allowing many of us long term investors to purchase so many more shares at rediculously low prices!

Simufilam boosts soluble level of Amyloid bera42 which in turn improves or maintains cognition in Alz patients This, along with its superior safety profile, will win the approval undoubtedly!

NEW MOA of Simufilam - boosting soluble Amyloid beta42 levels hence improving cognition.